Tag: health care
-
Over-the-Counter Naloxone Receiving Faster FDA Review
The opioid overdose drug naloxone in nasal spray form is receiving priority review from the Food and Drug Administration as an over-the-counter drug.
-
Infographic – Higher HIV Burden for Women, Girls in Africa
The data show falling numbers of young men and women in sub-Saharan Africa with new HIV infections since 2010, but the percentage of infected women and girls also rising over that time.
-
Trial Shows Fast-Absorbing Opioid Overdose Nasal Swab
Results of a clinical trial show a nasal swab dispensing an opioid antidote transfers more of the antidote into the blood stream than syringe injections or nasal sprays.
-
Infographic – U.S. Dominates Diabetes Drug Sales
More than 133 million people have diabetes, nearly one-third of the world’s total, yet almost half of the world’s diabetes drug sales volume is in the U.S.
-
Mental Health Therapy, Tech Network Gains Early Funds
A company building a therapy and technology network for improving access to mental health providers is raising $15 million in its first venture round.
-
AI-Aided System to Identify Diabetes Complication Risks
Researchers at University of Houston are creating a system aided by algorithms for primary care physicians to better identify people at risk for complications from diabetes.
-
RSV Nose Drops Vaccine Gets FDA Fast Track Tag
A vaccine designed from engineered live viruses and taken as nose drops to prevent respiratory syncytial virus received a Food and Drug Administration fast-track designation.
-
Trial Shows Antibody Neutralizes, Reduces HIV Virus
Results from a clinical trial show an experimental one-time antibody therapy, even at low doses, lowers levels of HIV virus in people living with the disease.
-
New Funds Awarded for Rapid Infection Diagnostics
A developer of faster infection diagnostics is receiving another $8.2 million from an international group supporting solutions to antibiotic resistant microbes.
-
Nasal Spray Vaccines Get CEPI, NIH Funding
A developer of infectious disease vaccines is gaining funds for new nasal sprays protecting against a range of coronaviruses and the sexually-transmitted disease gonorrhea.